:: Volume 22, Issue 1 (3-2020) ::
J Gorgan Univ Med Sci 2020, 22(1): 71-76 Back to browse issues page
Survival rate of gasteric cancer in Golestan provience (north of Iran)
Siamak Razaei1 , Mohammad Hossein Taziki * 2, Nasser Behnampour3 , Reza Shahsavani4 , Seyyed Shfie Shafiepour5
1- Assistant Professor, Department of Surgery, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
2- Associate Professor, Department of Surgery, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran , hoseinta@yahoo.com
3- Ph.D in Biostatistics, Assistant Professor, School of Health, Golestan University of Medical Sciences, Gorgan, Iran.
4- Hematologist - Oncologist, Gorgan, Iran.
5- Cardiologist, Tehran University of Medical Scineces, Tehran. Iran.
Abstract:   (7650 Views)
Background and Objective: Due to high incidence and mortality of gasteric cancer and important of clinical symptoms to early diagnosis and tertment; this stady was done to determine the survival rate of gasteric cancer in Golestan provience (north of Iran).
Methods: This retrospective cohort stady was done on 131 patients (77.9% males and 22.1% females) with adeno carcinoma gasteric cancer wich diagosed during 2007-09 in northern Iran. Age, sex, job, nationality and tribe clincal presentation kind of treatment food regiemns, survival collected from archive. In cases whom nesacery data completed with telophone calling or face to face interview. Survival rate of patients for 1, 3 and 5 years were determined using caplan Mayer method.
Results: First symptom in 31.3% of patients was abdominl pain and distance between the first symptom and diagnosis was 1-14 months. 34.4% of patient did not receive any treatment. Survivial rate for 1, 3 and 5 years was 37.4%, 13% and 6.1%, respectively. Age, gender and ethnicity did not not altere survival rate but type of treatment had significant relation to survival rate (P<0.05).
Conclusion: The diagnosis of gasteric cancer in early stage and surgical treatment can help a better survival rate in patients with adeno carcinoma gasteric cancer in northern Iran.
Keywords: Gastric cancer, Epidemiology, Survival, Iran
Article ID: Vol22-10
Full-Text [PDF 200 kb]   (10587 Downloads)    
Type of Study: Original Articles | Subject: Epidemiology
1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997 May; 349(9063): 1436-42. doi: 10.1016/S0140-6736(96)07495-8
2. Mathers CD, Boschi- Pinto C, Lopez AD, Murray CJL. Cancer incidence, Mortality and survival by for 14 Region of the world. Global Programme on Evidence for Health Policy Discussion Paper No 13. World Health Organization. 2001.
3. Mousavi SM, Goya MM, Ramazani R, et al. [National Cancer Registry Report 2004–2005]. Tehran, Iran: Ministry of Health, Deputy for Health Directory, CDC Cancer Office 2007. [Persian]
4. Mehrbani D, Tabei SZ, Heydari ST, Shamsina SJ, Shokrpour N, Amini M, et al. Cancer Occurrence in Fars Province, Southern Iran. Iran Red Crescent Med J. 2008; 10(4): 314-22.
5. Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018 Feb; 10: 239-48. doi: 10.2147/CMAR.S149619
6. Hoda S, Aliee A, Shakiba M, Odi M, Ghasemi Poor M, Poor Rasooli Z. [A Study of Frequency of Cancerous Organs in Guilan Province (1999-2000)]. J Guilan Univ Med Sci. 2003; 12(46): 84-92. [Article in Persian]
7. Asplund J, Kauppila JH, Mattsson F, Lagergren J. Survival Trends in Gastric Adenocarcinoma: A Population-Based Study in Sweden. Ann Surg Oncol. 2018 Sep; 25(9): 2693-702. doi: 10.1245/s10434-018-6627-y
8. Esmaielee H. [Comparing survival rate ai characteristics of esophagus and stoi cancer in Mazandran province]. Dissertal School of Medicine Science. T Modarres Univ. 1992; pp: 18-39. [Persian]
9. Cormedi MCV, Katayama MLH, Guindalini RSC, Faraj SF, Folgueira MAAK. Survival and prognosis of young adults with gastric cancer. Clinics (Sao Paulo). 2018 Sep; 73(suppl 1): e651s. doi: 10.6061/clinics/2018/e651s
10. Yavari P, Mousavi Zadeh M, Sadroihefazi B, Khodabakhshi R, Mehrabi I, Madani H, Khoshnevis J. [Risk Factors Related to Breast Cancer in Women Referred to Shohadaye Tajrish Hospital in Tehran in 2004]. Pajoohande J. 2006; 11(7): 9-15. [Article in Persian]
11. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019 Apr; 144(8): 1941-53. doi: 10.1002/ijc.31937
12. Movahedi M, Afsharfard A, Moradi A, Nasermoaddeli A, Khoshnevis J, Fattahi F, et al. Survival rate of gastric cancer in Iran. J Res Med Sci. 2009 Nov-Dec; 14(6): 367-73.
13. Yazdannbod A, Arshi Sh, Derakhshan MH, Sadjadi AR, Malekzadeh R. Gastric cardia cancer; the most common type of upper gastrointestinal cancer in Ardabil, Iran: An endoscopy clinic experience. Arch Irn Med. 2001; 4(2): 76-79.
14. Mohagheghi MA. Annual report of Tehran cancer registry 1999. Tehran (Iran): The Cancer Institute Publication. 2004.
15. Mohagheghi MA, Musavi Jarahi A, Shariat Torbaghan S, Zeraati H. Annual Report of Tehran University of Medical Sciences District Cancer Registry 1997. The Cancer Institute Publication; 1999.
16. Semnani Sh, Roshandel Gh, Keshtkar A, Sadjadi A, Moradi A, Nouraie M, et al. Annual report of Golestan Population-based Cancer Registry, 2006. Number 3. Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences. 2008.
17. Taziki MH, Behnampour N. A Study of the Etiology of Referred Otalgia. Iran J Otorhinolaryngol. 2012; 24(69): 171-76.
18. Rajaiefard A, Moghimi B, Tabatabaie SH, Safaie A, Tabeie S Z. [Epidemiological and clinical features of gastric cancer: descriptive study of cancer registry cases of Fars province (2001-2006)]. Iran South Med J. 2011; 14(2): 114-21. [Article in Persian]
19. Yazdanbod E, Samadi F, Malekzade R, Babaie M, Iranparvar M, Azami A. [Four-Year Survival Rate of Patients with Upper GI Cancer in Ardabil]. J Ardabil Univ Med Sci. 2005; 5(2): 180-84. [Article in Persian]
20. Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, et al. Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer. 2003 Oct; 107(1): 113-18. doi: 10.1002/ijc.11359
21. Khabazkhoob M, Mohagheghi MA, Mosavi Jarrahi A, Javaher Foroushzadeh A, Pedram Far M, Moradi A, et al. [Incidence rate of gastrointestinal tract cancers in Tehran – Iran (1998-2001)]. J Gorgan Univ Med Sci. 2010; 11(4): 44-50. [Article in Persian]
22. Davoodabadi A, Sharifi H, Erfan N, Dianati M, Abdolrahim Kashi E. [An epidemiologic and clinical survey on gastric cancer patients refered to Shahid Beheshti hospital of Kashan (1994-2001)]. Razi J Med Sci. 2003; 10(34): 211-20. [Article in Persian]
23. Abdollahian M, Kaviani M, Solki S. [Evaluation of the frequency of Gastrointestinal Cancers in one of the Khorram Abad Hospitals]. Yafte. 2006; 7(4): 69-72. [Article in Persian]
24. Hajian K, Firouzjahi AR, Kia MT. [Pattern of Age Distribution of Different Cancers Babol, 2001]. Res Med. 2003; 27(3): 239-45. [Article in Persian]
25. Rashed Mohasel MA, Sheybani KH. [Gastric cancer: review of 230 cases]. J Med Counc I.R. Iran. 1982; 8(5): 320-25. [Article in Persian]
26. Molanaie N, Rahimi E, Aiobi S. [Epidemialogy of Colorectal Cancer in Kurdistan province during 1995-1999]. Scientific J Kurdistan Uni Med Sci. 2000; 5(1): 22-25. doi: 10.22102/5.1.5 [Article in Persian]
27. Koohsari M. [A Study on Lifestyle Habits and Gastric Cancer in Guilan Province]. J Guilan Univ Med Sci. 2004; 13(49): 10-19. [Article in Persian]
28. Saremi A, Heydari E. [Speculative risk factors of gastric cancer (A survey of ninty patients)]. Razi J Med Sci. 1994; 1: 81-88. [Article in Persian]
29. Iravani SH, Sadaghi Sh. [Epidemiologic Characteristics of Patients with Gastric Cancer Hospitalized in Shohada Tajrish Hospital from 2000-2005]. Ann Milit Health Sci Res. 2000; 12(8): 825-27. [Article in Persian]
30. Kocoglu H, Dogan H, Oguz B, Ocak Serin S, Okuturlar Y, Gunaldi M, et al. Comparison of Survival Rates, Tumor Stages, and Localization in between Obese and Nonobese Patients with Gastric Cancer. Gastroenterology Research and Practice. Volume 2016, Article ID 9382750. http://dx.doi.org/10.1155/2016/9382750
31. Modarres SR, Gholizadeh Pasha A, Siadati S. Estimating postoperative survival rate of gastric cancer patients and its effective factors in Babol, northern Iran: 2006-2011. Caspian J Intern Med. 2017; 8(3): 190-95. doi: 10.22088/cjim.8.3.190
32. Matsuda T, Saika K. The 5-Year Relative Survival Rate of Stomach Cancer in the USA, Europe and Japan. Jpn J Clin Oncol 2013; 43(11): 1157-58. doi:10.1093/jjco/hyt166
33. Tural D, Selçukbiricik F, Akar E, Serdengeçti S, Büyükünal E. Gastric cancer: A case study in Turkey. J Can Res Ther 2013; 9: 644-48. doi: 10.4103/0973-1482.126466
34. Semnani S, Besharat S, Kashtkar AA, Danesh A, Abdolahi N, Roshandel Gh, et al. [Short-term survival rates of upper gastrointestinal cancers in rural areas of Golestan province, Iran]. J Gorgan Univ Med Sci. 2008; 10(3): 51-57. [Article in Persian]

XML   Persian Abstract   Print

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 22, Issue 1 (3-2020) Back to browse issues page